	A Noise-Aware Robustness Evaluation Framework for Breast Cancer Classification in Ultrasound Imaging. J Imaging Inform Med Arriz-Jorquiera M, Bakht A, Uysal I, Del Toro MH, Lai-Yuen S, Zayas-Castro JL. PMID: 42463622 [PubMed - as supplied by publisher]
	A Prospective, Multicenter Randomized Controlled Trial (RCT) of the da Vinci SP(Â®) Surgical System versus Open Surgery in Nipple-Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer. Ann Surg Oncol Kopkash K, Piltin M, Jakub J, Javid S, Flanagan MR, Aft R, Chiba A, Lal A, Brooks AD, Amersi F, Dekhne N, Tseng J, Farley C, Kadison A, Johnson J, Hwang RF. PMID: 42463607 [PubMed - as supplied by publisher]
	An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer. Discov Oncol Zhang X, Cao M, Wu L, Zhao Y. PMID: 42463566 [PubMed - as supplied by publisher]
	Value of Axillary Palpation and Ultrasound, and Axillary Recurrence in Male Breast Cancer: Results of the Registry Study. Int J Cancer Graeser M, Bothin S, Gluz O, Warm M, Ignatov A, Eggemann H. PMID: 42463458 [PubMed - as supplied by publisher]
	Pregnancy-Associated Small Cell Carcinoma of the Ovary, Hypercalcaemic Type Initially Misdiagnosed as Granulosa Cell Tumour: Diagnostic Pitfalls, Treatment Challenges, and Molecular Confirmation by Next-Generation Sequencing. Cancer Rep (Hoboken) Kumar M, Kakoti L, Barmon D, Baruah U, Begum D, Roy PS, Bassetty KC, Mittal D, Seth B. PMID: 42463449 [PubMed - in process]
	Correspondence on "Differences in First-Line Chemosensitivity Assessed by KELIM in Advanced Serous Ovarian Cancer: Evidence From Western and Japanese Trials in a Gynecologic Cancer InterGroup (GCIG) Meta-Analysis" by Pauline Corbaux to the Editor of the International Journal of Gynecological Cancer. Int J Gynecol Cancer Ghalleb M, Alouini A. PMID: 42463394 [PubMed - as supplied by publisher]
	Recent advances in understanding the role of chemokines in breast cancer microenvironment remodelling. Pathol Res Pract Qiu X, Zhang H, Liu Y, Zhang G, Liu J, Hu J, Liu H, Ran K, Zhang C. PMID: 42462382 [PubMed - as supplied by publisher]
	BRK/PTK6 in breast cancer: prognostic and therapeutic significance. Cancer Treat Res Commun Dokunmu TM, Nnaji FC, Amuji DN, Wakai TN, Amadi EC. PMID: 42462367 [PubMed - as supplied by publisher]
	Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update. J Clin Oncol Nahleh Z, Alfano CM, Somerfield MR, Lee JM, Hieken TJ, Magnuson A, Rao RD, Chew HK, Chia SKL, Harvey BE, Landsberger E, Lim B, Mwanzi SA, Parsons HA, Patt D, Sukumar JS, Sung H, Werutsky G, Lustberg M. PMID: 42462191 [PubMed - as supplied by publisher]
	Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer. PLoS One Mäenpää N, Tiainen L, Martikainen J, Tanner M, Jukkola A, Bärlund M. PMID: 42461910 [PubMed - indexed for MEDLINE]
	Progression-Free Survival in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review: A Systematic Review and Meta-Analysis. JAMA Oncol Ravani LV, Bagheri Z, Kalinsky K, Burstein HJ, Bardia A, Mouabbi JA, O'Regan R, Wander SA. PMID: 42461660 [PubMed - as supplied by publisher]
	Comparative and Dose-Response Effects of Exercise Modalities on Sleep Quality in Individuals With Breast Cancer: A Bayesian Network Meta-Analysis. Psychooncology Guo Y, Xin X, Li X, Wang P, Qi Z, Liu Q, Jiao M, Liang Z, Liu Q. PMID: 42461508 [PubMed - indexed for MEDLINE]
	Beyond chemotherapy: the evolving role of photodynamic therapy in triple-negative breast cancer. Med Oncol Rashwan HH, Azzazy HME. PMID: 42461456 [PubMed - indexed for MEDLINE]
	Laser, radiofrequency, and promestriene in the treatment of genitourinary syndrome of menopause in breast cancer survivors: randomized clinical trial. Int Urogynecol J Dedonatto C, Bianchi-Ferraro AMHM, Dardes RCM, Sartori MGF, LARF- Study group, Patriarca MT. PMID: 42461278 [PubMed - as supplied by publisher]
	Dosimetric Comparison of Particle Radiotherapy and Photon VMAT for Left-Sided Breast Cancer Post Breast-Conserving Surgery. Technol Cancer Res Treat Huang W, Lei R, Deng X, Ma X, Jiang P, Wu J, Niu T, Meng W, Ye Y, Wang J. PMID: 42461153 [PubMed - indexed for MEDLINE]
	BRCA1 rs799917 and rs1799966 Variants and Breast Cancer Risk in Nigerian Women: A Case-Control Study With Population-Based Allele Frequency Analysis. Cancer Control Oluwabusayo OB, Onyia AF, Olasehinde OE, Paimo OK, Sylvester DC, Lasebikan NN, Lawal A, Alabi A, Sowunmi A, Aje EA, Shagaya U, Nwachukwu E, Oyekan A, Olatunji T, Fatiregun O, Ogo C, Nkom ES, Omonisi AE, Popoola OB, Ahmadu OT, Campos OC, Rotimi OA, Ajibola TO, Anake TA, Aliyu UM, Rotimi SO. PMID: 42461103 [PubMed - indexed for MEDLINE]
	US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective study. Future Oncol Nakayama J, Richey M, Patel K, Hartman J, Kiss Z, Cooney M, Kalayjian A, Hurteau JA. PMID: 42460506 [PubMed - as supplied by publisher]
	Can machine learning predict endometrial cancer in patients with postmenopausal uterine bleeding? Prz Menopauzalny Gluska H, Gnaiem N, Katz AA, Miller N, Tzidki A, Baron A, Hants Y, Beiner M, Asali A. PMID: 42460257 [PubMed]
	Cardiovascular toxicity of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in HR+/HER2- breast cancer: a real-world study based on the FAERS database. Front Pharmacol Ma S, Li L, Chen Y, Zhao Y. PMID: 42460021 [PubMed]
	A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support. Front Artif Intell Nannepaga JS, Kandati K, Matam M, Lohitha Nayeneni S, Priya Adem M. PMID: 42459767 [PubMed]

Articles 1 - 20 / 332269

Page 1 of 16614



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy